NCT05780957 Multi-Cancer Early Detection (MCED) of Firefighters
| NCT ID | NCT05780957 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Vincere Cancer Center |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2023-03-21 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2023-03-21 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is an an observational prospective cohort research study to explore the performance of new blood and urine tests for the early detection of cancer among firefighters.
Eligibility Criteria
Inclusion Criteria: * 18 years of age or older * Currently employed as a firefighter, full-time or part-time * Taking part in Vincere's First Responder Cancer Screening Program * Able to donate blood and urine sample * Able to provide informed consent to participate in the study Exclusion Criteria: * Deemed medically unfit for sample donation * Personal history of cancer in the last 5 years (with the exception of non-melanoma skin cancer)
Contact & Investigator
Vershalee Shukla, MD
PRINCIPAL INVESTIGATOR
Vincere Cancer Center
Frequently Asked Questions
Who can join the NCT05780957 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05780957 currently recruiting?
Yes, NCT05780957 is actively recruiting participants. Contact the research team at drlau@vincerecancer.com for enrollment information.
Where is the NCT05780957 trial being conducted?
This trial is being conducted at Scottsdale, United States.
Who is sponsoring the NCT05780957 clinical trial?
NCT05780957 is sponsored by Vincere Cancer Center. The principal investigator is Vershalee Shukla, MD at Vincere Cancer Center. The trial plans to enroll 2,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.